Featured Research

from universities, journals, and other organizations

Fighting Cancer With Aspirin?

Date:
October 3, 2006
Source:
Federation of American Societies for Experimental Biology
Summary:
When looking for new weapons in the war on cancer, scientists should turn to their medicine cabinets for an age-old remedy -- aspirin. Scientists at the University of Newcastle have determined that aspirin has cancer-fighting effects extending beyond Cox inhibitors. This finding, appearing in the October 2006 issue of the FASEB Journal, allows researchers to pursue new lines of investigation that could ultimately yield a new type of cancer-fighting drug.

When looking for new weapons in the war on cancer, scientists should turn to their medicine cabinets for an age-old remedy--aspirin. According to scientists at the University of Newcastle (UK), aspirin has cancer-fighting effects that extend beyond already understood Cox inhibitors.

Related Articles


This finding, which appears in the October 2006 issue of The FASEB Journal, provides important clues to how aspirin works in cancer and in inflammation: aspirin reduces the formation of blood vessels that fuel developing tumors. Without new blood vessels (formed through a process called angiogenesis) tumors cannot grow. With this information, researchers can pursue new lines of investigation that could ultimately yield an entirely new type of cancer-fighting drug.

In the study, the researchers show that aspirin acts on the signaling molecule NFkappaB, which is known to trigger the formation of new blood vessels, an important part of tumor development. Additionally, Newcastle researchers found a dose-dependent relationship between blood vessel formation and the amount of aspirin used in the study. This new finding confirms and extends earlier evidence suggesting that NFkappaB is a target of aspirin action in inflammation; now researchers can work out exactly how signals interrupted by aspirin can control not only inflammation, but the biology of tumor growth as well.

"Aspirin has always been touted as a 'wonder drug,'" said Gerald Weissmann, MD, Editor-in-Chief of The FASEB Journal, "and this study shows that we are still learning about the many actions of this amazing drug."

The FASEB Journal (http://www.fasebj.org) is published by the Federation of American Societies for Experimental Biology (FASEB) and is consistently ranked among the top three biology journals worldwide by the Institute for Scientific Information. FASEB comprises 21 nonprofit societies with more than 80,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB's mission is to enhance the ability of biomedical and life scientists to improve -- through their research -- the health, well-being and productivity of all people. FASEB serves the interests of these scientists in those areas related to public policy, facilitates coalition activities among member societies and disseminates information on biological research through scientific conferences and publications.


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Cite This Page:

Federation of American Societies for Experimental Biology. "Fighting Cancer With Aspirin?." ScienceDaily. ScienceDaily, 3 October 2006. <www.sciencedaily.com/releases/2006/10/061002215512.htm>.
Federation of American Societies for Experimental Biology. (2006, October 3). Fighting Cancer With Aspirin?. ScienceDaily. Retrieved April 19, 2015 from www.sciencedaily.com/releases/2006/10/061002215512.htm
Federation of American Societies for Experimental Biology. "Fighting Cancer With Aspirin?." ScienceDaily. www.sciencedaily.com/releases/2006/10/061002215512.htm (accessed April 19, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, April 19, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Our Love Of Puppy Dog Eyes Explained By Science

Our Love Of Puppy Dog Eyes Explained By Science

Newsy (Apr. 17, 2015) Researchers found a spike in oxytocin occurs in both humans and dogs when they gaze into each other&apos;s eyes. Video provided by Newsy
Powered by NewsLook.com
Dr. Oz Under Fire For 'Quack Treatments' Yet Again

Dr. Oz Under Fire For 'Quack Treatments' Yet Again

Newsy (Apr. 17, 2015) Ten doctors signed a letter urging Columbia University to drop Dr. Oz as vice chair of its department of surgery, saying he plugs "quack" treatments. Video provided by Newsy
Powered by NewsLook.com
Scientists Find Link Between Gestational Diabetes And Autism

Scientists Find Link Between Gestational Diabetes And Autism

Newsy (Apr. 17, 2015) Researchers who analyzed data from over 300,000 kids and their mothers say they&apos;ve found a link between gestational diabetes and autism. Video provided by Newsy
Powered by NewsLook.com
Video Messages Help Reassure Dementia Patients

Video Messages Help Reassure Dementia Patients

AP (Apr. 17, 2015) Family members are prerecording messages as part of a unique pilot program at the Hebrew Home in New York. The videos are trying to help victims of Alzheimer&apos;s disease and other forms of dementia break through the morning fog of forgetfulness. (April 17) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins